Schizophrenia Research Trends

Body Image Deviation in Chronic Schizophrenia: New Research 21normal control group of study 1 was used. All of the study participants were informed of thepurpose of the study and actively participated with a written informed consent. (See Table 7.)Table 7. Demographic and clinical characteristics of subjects. (Study 2.)Schizophrenia Anxiety Disorders Normals(N=83) (N=43) N=177Demographic characteristicsMean Age 48.2 39.1 44.9Gender (Male %) 53.0 53.4 44.0Clinical characteristics of the schizophrenic patientsMean (Range)Age of Onset 24.2 (14-45)Years of Hospitalization 23.7 (3-47)Dose of CPZ (mg/day) 437.0 (30-1256)Data AnalysisMeans of the three BIQ component scores were compared among groups withschizophrenia, anxiety disorders and normals using ANOVA, followed by multiplecomparisons using the Tukey method. The means of each item score of the differentialcomponent scores obtained were compared between the schizophrenic and non-schizophrenicgroups using ANOVA.ResultsThe results of ANOVA are shown in Table 8, and the results of succeeded multiplecomparisons are shown in Table 12. Statistically significant group differences in means werefound in the BIQ functional component score (F=12.478, df=2/284, p=0.000). Furthermultiple comparisons of differences of means showed a statistically significant differencebetween groups with schizophrenia and anxiety disorders (p =0.021), and between groupswith schizophrenia and normal groups (p = 0.000). There was no statistically significantdifference among the three diagnostic groups in the BIQ anatomical component score or inthe BIQ psychological component score.The mean scores of BIQ functional items, which composed the differential component,were further compared between schizophrenic and non-schizophrenic groups. Eight out of 17items showed statistically significant differences, including being weak (F=7.262, df=2,p